Tata India Pharma & Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8569 Cr | ₹1282 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 21% | 26.49% |
Expense Ratio | 1.82 | 2.14 |
Manager | Sailesh Raj Bhan | Meeta Shetty |
ISIN Code | INF204K01968 | INF277K016A9 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -0.12% | 1.69% |
6 Month | 7.59% | 4.32% |
1 Year | 5.16% | 5.37% |
3 Year | 23.28% | 23.23% |
5 Year | 19.57% | 19.67% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 7.77% | 7.46% |
1 Year | 12.61% | 9.63% |
3 Year | 25.2% | 25.05% |
5 Year | 20.43% | 20.35% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 17.31% | 10.55% |
3 Year | 20.52% | 18.34% |
5 Year | 20.64% | 15.18% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 14.75% | 15.93% |
Sharp | 1.20% | 1.09% |
Beta | 0.90% | 0.99% |
Alpha | 0.72% | -1.23% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Meeta Shetty |
Total AUM | ₹96086 Cr | ₹17847 Cr |
Funds Managed | 5 | 5 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 0.53 | 10.06 |
Large Cap | 35.06 | 27.56 |
Mid Cap | 31.99 | 32.77 |
Small Cap | 32.41 | 29.61 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 0.53 | 7.68 |
Healthcare | 99.47 | 89.02 |
Basic Materials | - | 2.34 |
Financial Services | - | 0.96 |
Top Comparisons
SBI Large Cap Fund-Regular Plan Growth
3Y Returns14.45%
Tata Large Cap Fund -Regular Plan - Growth Option
3Y Returns14.32%
HDFC Low Duration Fund - Growth
3Y Returns7.25%
Aditya Birla Sun Life Low Duration Fund - Growth Plan
3Y Returns6.93%
HDFC Large and Mid Cap Fund - Growth Option
3Y Returns20.36%
LIC MF Large & Mid Cap Fund Regular-Growth
3Y Returns16.45%
ICICI Prudential Commodities Fund - Growth Option
3Y Returns21.03%
Kotak Pioneer Fund- Regular Plan- Growth Option
3Y Returns22.5%